Is Librax a Controlled Substance? Its Unique Legal Status

Librax contains a controlled substance but is itself exempt from controlled substance scheduling under federal law. This unusual status exists because one of its two active ingredients, chlordiazepoxide, is a Schedule IV controlled substance on its own, while the combination product has been granted an exemption from the Controlled Substances Act by the DEA.

Why Librax Has a Unique Legal Status

Librax is a combination of two drugs: chlordiazepoxide, a benzodiazepine that reduces anxiety and tension, and clidinium bromide, an anticholinergic that slows gut spasms and reduces stomach acid. The benzodiazepine component is what triggers controlled substance concerns. Chlordiazepoxide prescribed by itself is classified as Schedule IV, meaning it has a recognized potential for misuse and dependence, though lower than drugs in Schedules I through III.

However, when chlordiazepoxide is combined with clidinium bromide in the specific formulation sold as Librax, the DEA grants the product an exemption. The DEA maintains a “Table of Exempted Prescription Products” that lists Librax (and dozens of generic equivalents from various manufacturers) as exempt from Schedule IV controls. As of the most recent version of that table, dated April 2026, this exemption remains in place.

In practical terms, this means Librax is still a prescription medication, but pharmacies and prescribers don’t have to follow every rule that applies to a standard Schedule IV drug. You won’t encounter the same level of tracking or restrictions you might with other benzodiazepines like lorazepam or diazepam prescribed alone.

What This Means for Your Prescription

Even though Librax is federally exempt from scheduling, many of the prescription rules for Schedule III and IV drugs still serve as a practical framework. Under federal law, prescriptions for Schedule III and IV substances cannot be refilled more than five times, and they expire six months after the date they were written. After that, your prescriber needs to issue a new prescription. Because Librax contains a benzodiazepine, many pharmacies and state boards apply similar handling rules even with the exemption in place.

State laws can also affect how Librax is handled at the pharmacy counter. Texas, for example, lists chlordiazepoxide as a Schedule IV substance consistent with federal classification, and some states may choose to treat the combination product more cautiously than federal rules require. If you’re having trouble filling or refilling a Librax prescription, your state’s regulations may be stricter than the federal exemption suggests.

What Librax Is Prescribed For

Librax is designed to treat gastrointestinal conditions where anxiety plays a role in worsening symptoms. The chlordiazepoxide component calms the nervous system, while the clidinium bromide component directly targets the gut by reducing acid production and relaxing intestinal muscle spasms. This dual action makes it useful for conditions like irritable bowel syndrome (IBS) and peptic ulcers, particularly when stress or anxiety amplifies digestive symptoms.

Dependence and Withdrawal Risks

The exemption from scheduling does not mean Librax is free of dependence risk. The benzodiazepine it contains can cause physical dependence, especially with longer use or higher doses. The FDA label for Librax carries a boxed warning, the most serious type, covering three risks: dangerous interactions with opioids, the potential for abuse and addiction, and dependence with withdrawal reactions.

Stopping Librax abruptly after regular use can trigger withdrawal symptoms including seizures, stomach cramps, muscle cramps, tremors, and unusual behavior. These reactions can be life-threatening. The FDA recommends a gradual taper rather than sudden discontinuation, with the pace adjusted based on how you respond. If withdrawal symptoms appear during the taper, the typical approach is to pause or step back to the previous dose and then reduce more slowly.

Chlordiazepoxide on its own is generally intended for short-term use, typically 7 to 10 days. When Librax is prescribed for longer periods to manage a chronic condition like IBS, the risk of dependence increases, which makes a supervised tapering plan especially important when it’s time to stop.

The Opioid Interaction Warning

Librax’s boxed warning specifically flags the danger of taking it alongside opioid medications. Combining benzodiazepines with opioids can cause extreme sedation, dangerously slow breathing, coma, and death. If you’re taking any opioid, whether prescribed for pain or used in medication-assisted treatment, this combination requires careful oversight. The FDA guidance is to use the lowest effective doses of both for the shortest time necessary.